NovoCure
NVCR
NVCR
161 hedge funds and large institutions have $1.66B invested in NovoCure in 2018 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 64 increasing their positions, 33 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
25% more funds holding
Funds holding: 129 → 161 (+32)
9.36% more ownership
Funds ownership: 48.97% → 58.33% (+9.4%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
161
Holding in Top 10
4
Calls
$23.2M
Puts
$5.26M
Top Buyers
| 1 | +$58.8M | |
| 2 | +$46.5M | |
| 3 | +$27.6M | |
| 4 |
BlackRock
New York
|
+$26.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.3M |
Top Sellers
| 1 | -$23.5M | |
| 2 | -$16.2M | |
| 3 | -$15.6M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$8.31M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$8.14M |